IGC Pharma, Inc.IGCNYSE
Loading
Operating Expenses Over TimeContracting
Percentile Rank64
3Y CAGR-19.8%
5Y CAGR+2.9%
Year-over-Year Change
Expenses from normal business operations (SG&A, R&D, etc.)
3Y CAGR
-19.8%/yr
vs +70.0%/yr prior
5Y CAGR
+2.9%/yr
Recent deceleration
Acceleration
-89.8pp
Decelerating
Percentile
P64
Within normal range
vs 5Y Ago
1.2x
Modest growth
Streak
3 yr
Consecutive declineContracting
| Period | Value | YoY Change |
|---|---|---|
| 2025 | $8.06M | -23.4% |
| 2024 | $10.53M | -7.7% |
| 2023 | $11.41M | -26.9% |
| 2022 | $15.62M | +86.5% |
| 2021 | $8.38M | +20.0% |
| 2020 | $6.98M | +46.2% |
| 2019 | $4.78M | +155.3% |
| 2018 | $1.87M | -17.7% |
| 2017 | $2.27M | -39.4% |
| 2016 | $3.75M | - |